Verano Holdings (VRNO) Other Non Operating Income (2022 - 2026)
Verano Holdings (VRNO) posted quarterly Other Non Operating Income of -$1.2 million for Q1 2026, down 125.79% year-over-year from $4.7 million in Q1 2025, and up 91.86% quarter-over-quarter from -$15.0 million in Q4 2025.
Verano Holdings (VRNO) Other Non Operating Income (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Other Non Operating Income for 5 consecutive years, with -$1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 125.79% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$15.0 million (down 372.34% YoY), while the FY2025 annual figure was -$10.3 million, changed N/A from the prior year.
- Other Non Operating Income advanced to -$1.2 million in Q1 2026 per VRNO's latest filing, from -$15.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $31.6 million in Q4 2022 and bottomed at -$15.0 million in Q4 2025.
- Historically, Other Non Operating Income has averaged $1.7 million across 5 years, with a median of -$484000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Non Operating Income surged 460.5% — and 2025, when it slumped 715.83%.
- Verano Holdings' Other Non Operating Income stood at $31.6 million in 2022, then plunged by 108.03% to -$2.5 million in 2023, then surged by 195.91% to $2.4 million in 2024, then plunged by 715.83% to -$15.0 million in 2025, then surged by 91.86% to -$1.2 million in 2026.
- Business Quant data shows VRNO's Other Non Operating Income at -$1.2 million in Q1 2026, -$15.0 million in Q4 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Verano Holdings | 445.39 Mn | 360.20 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.38 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -15.01 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | -484,000.00 |
| Jun 30, 2024 | -1.20 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | -1.41 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 31.64 Mn |
| Sep 30, 2022 | -595,000.00 |